Key facts
- MedVet Associates’s last known valuation is $284.5M (Jul 2019).
- It has raised $66.4M across 35 recorded rounds; the latest was Seed Round ($3.2M) in Apr 2026.
- Notable investors include Goldman Sachs Asset Management, Leonard Green & Partners.
- MedVet Associates has filed 36 Form Ds with the SEC since 2015, most recently Apr 2025 ($2.4M sold to 40 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 35 rounds
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for MedVet Associates
Funding rounds
35 roundsAbout MedVet Associates
Operator of a chain of veterinary emergency and specialty referral veterinary hospitals intended for companion animals. The company offers a range of services, including pain management, cardiology, oral surgery, interventional radiology, and medical oncology, along with specialty referral services for in-depth care, thereby enabling veterinarians and pet owners to access specialized medical treatment for animals.
- Sector
- Healthcare
- HQ
- Worthington, OH, United States
- Founded
- 1988
- Employees
- 1,941
- Website
- medvet.com/
- Ownership
- Privately Held (backing)
MedVet Associates doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MedVet Associates shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MedVet Associates in its N-PORT filings yet. We sweep new filings monthly.